Cargando…
Use of Nebulized Amphotericin B in the Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
Background. Systemic steroids and adjunctive antifungal therapy are the cornerstone in treating allergic bronchopulmonary aspergillosis (ABPA) in the context of CF. Aim. Evaluate the use of inhaled amphotericin B (iAMB) as antifungal agent in this context. Methods. Report of 7 CF patients with recur...
Autores principales: | Proesmans, M., Vermeulen, F., Vreys, M., De Boeck, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014676/ https://www.ncbi.nlm.nih.gov/pubmed/21234103 http://dx.doi.org/10.1155/2010/376287 |
Ejemplares similares
-
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018) -
Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
por: Knutsen, Alan P., et al.
Publicado: (2011) -
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Janahi, Ibrahim Ahmed, et al.
Publicado: (2017) -
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Alyasin, Soheila, et al.
Publicado: (2018) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018)